KENYANS WARNED AGAINST MISUSE OF OZEMPIC

The Pharmacy and Poisons Board (PPB) has issued a warning to Kenyans regarding the misuse of semaglutide compounds, commonly known by the brand name Ozempic for weight loss purposes. The Board emphasized that semaglutide is a Prescription-Only Medicine and should not be used without proper medical oversight, citing the potential for serious health risks when used off-label. In a statement released on Tuesday August 19, 2025, the PPB acknowledged that while semaglutide is effective in managing type 2 diabetes that is not well-controlled, its growing use for non-approved purposes such as weight loss continues to raise significant safety concerns.

“Semaglutide is approved for the treatment of adults with type 2 diabetes mellitus that is insufficiently controlled,” the Board stated. “Although the benefits outweigh the risks when used correctly, serious safety issues arise when the drug is misused for purposes outside of its approved medical use.” The PPB noted that semaglutide marketed under brand names such as Ozempic and various generics can cause side effects ranging from mild to severe. These include hypoglycaemia (low blood sugar), eye complications, acid reflux, and intestinal obstruction.

The public has been strongly urged to avoid off-label use of semaglutide and to report any suspected adverse effects or substandard medicines through the Board’s official reporting channels. Reports can be submitted via The Pharmacovigilance Electronic Reporting System: pv.pharmacyboardkenya.org “The Board appreciates the continued cooperation of the public in ensuring the safe use of medicines,” the statement concluded. This warning comes amid rising reports of semaglutide being used for weight loss across Kenya and increasing concerns about counterfeit versions entering the market.

Public Health Principal Secretary Mary Muthoni also addressed the issue recently, confirming that swift regulatory measures are being implemented to protect consumers and uphold responsible prescription and dispensing of pharmaceuticals.